IPA is empowering a new era of biotherapeutic intelligence with a hybrid of expertise and technologies in the SCIENCE and BUSINESS of bioplatform-based discovery.
See drug discovery through a new lens with a practical take on how multi-omics analysis can be a truly accessible and fast way to turn data into knowledge — and knowledge into precision medicine.